// App-Quantinova.ai

4450 : Silencing NKD2 by promoter region hypermethylation promotes esophageal cancer progression by activating Wnt signaling

Researchers

Presenter

  • Mingzhou Guo

Principal Investigators

  • Baoping Cao

  • Weili Yang

  • Yongshuai Jin

  • Meiying Zhang

  • Tao He

  • Qimin Zhan

  • James G. Herman

  • Guanglin Zhong

Medical Centers

  • PLA General Hospital, Beijing, China

  • Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

  • University of Pittsburgh Cancer Institute, Pittsburgh, PA

Locations

  • United States

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Esophageal squamous carcinoma cell

  • Esophageal Cancer

  • Breast cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Decitabine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved